药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2014年
4期
356-358
,共3页
沈纪中%王磊%夏永泉%葛卫红
瀋紀中%王磊%夏永泉%葛衛紅
침기중%왕뢰%하영천%갈위홍
超重%肥胖%肝功能指标
超重%肥胖%肝功能指標
초중%비반%간공능지표
Overweight%Obesity%indices of liver function
目的:研究超重或肥胖与不同肝功能指标间的关系。方法:在体检人群中选择192例受检者,分别测量身高、体重、血压,检测血脂、血糖、肝功能相关多项指标。结果:超重或肥胖者表现出多项代谢异常,包括:血压升高、血糖升高、血脂紊乱。与正常体重组比较,超重或肥胖组的肝功能相关血清酶水平均出现显著的升高(P<0.05)。调整年龄和性别变量后的多因素回归分析提示,超重或肥胖组谷丙转氨酶异常发生的危险性是正常体重组的2.405倍,95% CI (清除率)为1.121~5.157。结论:超重或肥胖与肝功能相关血清酶水平升高相关。
目的:研究超重或肥胖與不同肝功能指標間的關繫。方法:在體檢人群中選擇192例受檢者,分彆測量身高、體重、血壓,檢測血脂、血糖、肝功能相關多項指標。結果:超重或肥胖者錶現齣多項代謝異常,包括:血壓升高、血糖升高、血脂紊亂。與正常體重組比較,超重或肥胖組的肝功能相關血清酶水平均齣現顯著的升高(P<0.05)。調整年齡和性彆變量後的多因素迴歸分析提示,超重或肥胖組穀丙轉氨酶異常髮生的危險性是正常體重組的2.405倍,95% CI (清除率)為1.121~5.157。結論:超重或肥胖與肝功能相關血清酶水平升高相關。
목적:연구초중혹비반여불동간공능지표간적관계。방법:재체검인군중선택192례수검자,분별측량신고、체중、혈압,검측혈지、혈당、간공능상관다항지표。결과:초중혹비반자표현출다항대사이상,포괄:혈압승고、혈당승고、혈지문란。여정상체중조비교,초중혹비반조적간공능상관혈청매수평균출현현저적승고(P<0.05)。조정년령화성별변량후적다인소회귀분석제시,초중혹비반조곡병전안매이상발생적위험성시정상체중조적2.405배,95% CI (청제솔)위1.121~5.157。결론:초중혹비반여간공능상관혈청매수평승고상관。
To study the association between overweight or obesity and different indices of liver function. Methods: A total of 192 subjects were selected and their body weight, height, blood pressure and biochemistry items including fasting blood glucose, lipid levels and indices of liver function were detected. Results: The overweight or obese subjects exhibited metabolic abnormalities, including high blood pressure, hyperglycemia and hyperlipemia. Compared with normal weight group, the liver function related serum enzyme levels of overweight or obese group were significantly increased (P<0.05). The results of multivariate logistic regression analysis after adjusted by age and gender showed that the OR value for alanine aminotransferase abnormalities in subjects with overweight or obesity was 2.405 times over normal weight subjects (95% CI: 1.121~5.157). Conclusion: Overweight or obesity is associated with elevated liver function related serum enzyme levels.